Thomas F.E. Barth

482 total citations
9 papers, 361 citations indexed

About

Thomas F.E. Barth is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Thomas F.E. Barth has authored 9 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in Thomas F.E. Barth's work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Renal and related cancers (2 papers). Thomas F.E. Barth is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Renal and related cancers (2 papers). Thomas F.E. Barth collaborates with scholars based in Germany, Canada and China. Thomas F.E. Barth's co-authors include Martin Bentz, Michael Baudis, Peter Lichter, Stephan Stilgenbauer, Peter M�ller, German Ott, Hans Konrad M�ller-Hermelink, Lars Bullinger, Michael J. Schwerer and Andreas Viardot and has published in prestigious journals such as International Journal of Molecular Sciences, Haematologica and Genes Chromosomes and Cancer.

In The Last Decade

Thomas F.E. Barth

9 papers receiving 359 citations

Peers

Thomas F.E. Barth
Julie C. Porcher United States
Agata M. Bogusz United States
Stefano Rosati Netherlands
MQ Du United Kingdom
S H Swerdlow United States
Julie C. Porcher United States
Thomas F.E. Barth
Citations per year, relative to Thomas F.E. Barth Thomas F.E. Barth (= 1×) peers Julie C. Porcher

Countries citing papers authored by Thomas F.E. Barth

Since Specialization
Citations

This map shows the geographic impact of Thomas F.E. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F.E. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F.E. Barth more than expected).

Fields of papers citing papers by Thomas F.E. Barth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F.E. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F.E. Barth. The network helps show where Thomas F.E. Barth may publish in the future.

Co-authorship network of co-authors of Thomas F.E. Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F.E. Barth. A scholar is included among the top collaborators of Thomas F.E. Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F.E. Barth. Thomas F.E. Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Steixner-Kumar, Agnes A., Diana Santacruz, Tobias Geiger, et al.. (2025). Single-cell landscape of peripheral immune cells in MASLD/MASH. Hepatology Communications. 9(5). 1 indexed citations
2.
Kraus, Johann M., Annika Scheffold, Thomas F.E. Barth, et al.. (2018). YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion. International Journal of Molecular Sciences. 19(12). 3801–3801. 18 indexed citations
3.
Wei, Jiwu, et al.. (2014). Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice. Haematologica. 99(6). 1050–1061. 9 indexed citations
4.
Kornmann, Marko, Alexander Kleger, Thomas F.E. Barth, et al.. (2013). Absence of FLICE-Inhibitory Protein Is a Novel Independent Prognostic Marker for Very Short Survival in Pancreatic Ductal Adenocarcinoma. Pancreas. 42(7). 1114–1119. 8 indexed citations
5.
Serra, Annalisa, Katharina Eirich, Annika Winkler, et al.. (2012). Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia. Molecular Syndromology. 3(3). 120–130. 13 indexed citations
6.
Bentz, Martin, Thomas F.E. Barth, Michael J. Schwerer, et al.. (2001). Gain of chromosome arm 9p is characteristic of primary mediastinal b-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes and Cancer. 30(4). 393–401. 105 indexed citations
7.
Barth, Thomas F.E., Martin Bentz, Frank Leithäuser, et al.. (2001). Molecular‐cytogenetic comparison of mucosa‐associated marginal zone B‐cell lymphoma and large B‐cell lymphoma arising in the gastro‐intestinal tract. Genes Chromosomes and Cancer. 31(4). 316–325. 66 indexed citations
8.
Barth, Thomas F.E., et al.. (2000). Risk of false positive results in comparative genomic hybridization. Genes Chromosomes and Cancer. 28(3). 353–357. 22 indexed citations
9.
Bentz, Martin, Lars Bullinger, Stephan Stilgenbauer, et al.. (2000). t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes and Cancer. 27(3). 285–294. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026